Moreover, in an immunohistochemical study performed on 48 human PDAC tissues, Adora2a was overexpressed, and high Adora2a PDAC expression was associated with more aggressive cases and later tumor stages at the time of diagnosis (62). This evidence concerns the gene ADORA2A and neoplasm.